Risk factors for tissue expander infection in scar reconstruction: a retrospective cohort study of 2374 consecutive cases

Chen Dong , Minhui Zhu , Luguang Huang , Wei Liu , Hengxin Liu , Kun Jiang , Zhou Yu , Xianjie Ma

Burns & Trauma ›› 2021, Vol. 9 ›› Issue (1) : tkaa037

PDF (654KB)
Burns & Trauma ›› 2021, Vol. 9 ›› Issue (1) :tkaa037 DOI: 10.1093/burnst/tkaa037
Research Article
research-article
Risk factors for tissue expander infection in scar reconstruction: a retrospective cohort study of 2374 consecutive cases
Author information +
History +
PDF (654KB)

Abstract

Background: Tissue expansion is used for scar reconstruction owing to its excellent clinical outcomes; however, the complications that emerge from tissue expansion hinder repair. Infection is considered a major complication of tissue expansion. This study aimed to analyze the perioperative risk factors for expander infection. Methods: A large, retrospective, single-institution observational study was carried out over a 10-year period. The study enrolled consecutive patients who had undergone tissue expansion for scar reconstruction. Demographics, etiological data, expander-related characteristics and post-operative infection were assessed. Univariate and multivariate logistic regression analysis were performed to identify risk factors for expander infection. In addition, we conducted a sensitivity analysis for treatment failure caused by infection as an outcome. Results: A total of 2374 expanders and 148 cases of expander infection were assessed. Treatment failure caused by infection occurred in 14 expanders. Multivariate logistic regression analysis identified that disease duration of ≤1 year (odds ratio (OR), 2.07; p <0.001), larger volume of expander (200–400 ml vs <200 ml; OR, 1.74; p=0.032; >400 ml vs <200 ml; OR, 1.76; p=0.049), limb location (OR, 2.22; p=0.023) and hematoma evacuation (OR, 2.17; p=0.049) were associated with a high likelihood of expander infection. Disease duration of ≤1 year (OR, 3.88; p=0.015) and hematoma evacuation (OR, 10.35; p=0.001) were so related to high risk of treatment failure. Conclusions: The rate of expander infection in patients undergoing scar reconstruction was 6.2%. Disease duration of <1 year, expander volume of >200 ml, limb location and postoperative hematoma evacuation were independent risk factors for expander infection.

Keywords

Tissue expansion / Tissue expander / Scar reconstruction / Risk factors / Infection

Cite this article

Download citation ▾
Chen Dong, Minhui Zhu, Luguang Huang, Wei Liu, Hengxin Liu, Kun Jiang, Zhou Yu, Xianjie Ma. Risk factors for tissue expander infection in scar reconstruction: a retrospective cohort study of 2374 consecutive cases. Burns & Trauma, 2021, 9 (1) : tkaa037 DOI:10.1093/burnst/tkaa037

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Neumann CG.The expansion of an area of skin by progressive distention of a subcutaneous balloon; use of the method for securing skin for subtotal reconstruction of the ear. PlastReconstrSurg(1946). 1957; 19: 124-30.

[2]

Radovan C. Breast reconstruction after mastectomy using the temporary expander. PlastReconstrSurg. 1982; 69: 195-208.

[3]

Ogawa R.Surgery for scar revision and reduction: from primary closure to flap surgery. BurnsTrauma. 2019; 7: 7. https://doi.org/10.1186/s41038-019-0144-5.

[4]

Min P, Li J, Brunetti B, Pu Z, Su W, Xi W, et al. Pre-expanded bipedicled visor flap: an ideal option for the reconstruction of upper and lower lip defects postburn in Asian males. BurnsTrauma. 2020. https://doi.org/10.1093/burnst/tkaa005.

[5]

Finnerty CC, Jeschke MG, Branski LK, Barret JP, Dziewulski P, Herndon DN. Hypertrophic scarring: the greatest unmet challenge after burn injury. Lancet. 2016; 388: 1427-36.

[6]

Bayat A, McGrouther DA, Ferguson MW. Skin scarring. BMJ. 2003; 326: 88-92.

[7]

Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, et al. Human skin wounds: a major and snowballing threat to public health and the economy. WoundRepairRegen. 2009; 17: 763-71.

[8]

Khansa I, Harrison B, Janis JE. Evidence-based scar management: how to improve results with technique and technology. PlastReconstrSurg. 2016; 138: 165S-78S.

[9]

Ma X, Li Y, Li W, Liu C, Peng P, Song B, et al. Reconstruction of large Postburn facial-scalp scars by expanded Pedicled Deltpectoral flap and random scalp flap: technique improvements to enlarge the reconstructive territory. JCraniofacSurg. 2017; 28: 1526-30.

[10]

Azzi JL, Thabet C, Azzi AJ, Gilardino MS. Complications of tissue expansion in the head and neck. HeadNeck. 2020; 42: 747-62.

[11]

Huang X, Qu X, Li Q. Risk factors for complications of tissue expansion: a 20-year systematic review and meta-analysis. PlastReconstrSurg. 2011; 128: 787-97.

[12]

Patel PA, Elhadi HM, Kitzmiller WJ, Billmire DA, Yakuboff KP. Tissue expander complications in the pediatric burn patient: a 10-year follow-up. AnnPlastSurg. 2014; 72: 150-4.

[13]

Motamed S, Niazi F, Atarian S, Motamed A. Post-burn head and neck reconstruction using tissue expanders. Burns. 2008; 34: 878-84.

[14]

As'adi K, Emami SA, Salehi SH, Shoar S. A randomized controlled trial comparing endoscopic-assisted versus open neck tissue expander placement in reconstruction of post-burn facial scar deformities. AestheticPlastSurg. 2016; 40: 526-34.

[15]

Tang S, Wu X, Sun Z, Cheng H, Shen H, Tang L, et al. Staged reconstructive treatment for extensive irregular cicatricial alopecia after burn. Medicine(Baltimore). 2018. https://doi.org/10.1097/MD.0000000000013522.

[16]

Abellan Lopez M, Serror K, Chaouat M, Mimoun M, Boccara D. Tissue expansion of the lower limb: retrospective study of 141 procedures in burn sequelae. Burns. 2018; 44: 1851-7.

[17]

Tayyaba FU, Amin MM, Attaur-Rasool S, Naseer U, Ambar A. Reconstruction of post burn scalp alopecia by using expanded hair-bearing scalp flaps. PakJMedSci. 2015; 31: 1405-10.

[18]

Adler N, Elia J, Billig A, Margulis A. Complications of nonbreast tissue expansion: 9 years experience with 44 adult patients and 119 pediatric patients. JPediatrSurg. 2015; 50: 1513-6.

[19]

Margulis A, Billig A, Elia J, Shachar Y, Adler N. Complications of post-burn tissue expansion reconstruction: 9 years experience with 42 Pediatric and 26 adult patients. IsrMedAssocJ. 2017; 19: 100-4.

[20]

Hanna KR, Tilt A, Holland M, Colen D, Bowen B, Stovall M, et al. Reducing infectious complications in implant based breast reconstruction: impact of early expansion and prolonged drain use. AnnPlastSurg. 2016; 76: S312-5.

[21]

Smolle C, Tuca A, Wurzer P, Spendel SM, Forbes AA, Spendel S, et al. Complications in tissue expansion: a logistic regression analysis for risk factors. Burns. 2017; 43: 1195-202.

[22]

Fochtmann A, Keck M, Mittlböck M, Rath T. Tissue expansion for correction of scars due to burn and other causes: a retrospective comparative study of various complications. Burns. 2013; 39: 984-9.

[23]

Nguyen KT, Hanwright PJ, Smetona JT, Hirsch EM, Seth AK, Kim JY. Body mass index as a continuous predictor of outcomes after expander-implant breast reconstruction. AnnPlastSurg. 2014; 73: 19-24.

[24]

Ota D, Fukuuchi A, Iwahira Y, Kato T, Takeuchi M, Okamoto J, et al. Identification of complications in mastectomy with immediate reconstruction using tissue expanders and permanent implants for breast cancer patients. BreastCancer. 2016; 23: 400-6.

[25]

Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. AnnSurg. 2009; 250: 187-96.

[26]

Bjornson LA, Bucevska M, Verchere C. Tissue expansion in pediatric patients: a 10-year review. JPediatrSurg. 2019; 54: 1471-6.

[27]

Karimi H, Latifi NA, Momeni M, Sedigh-Maroufi S, Karimi AM, Akhoondinasab MR. Tissue expanders; review of indications, results and outcome during 15 years’ experience. Burns. 2019; 45: 990-1004.

[28]

Gold MH, McGuire M, Mustoe TA, Pusic A, Sachdev M, Waibel J, et al. Updated international clinical recommendations on scar management: part 2-algorithms for scar prevention and treatment. DermatolSurg. 2014; 40: 825-31.

[29]

Monstrey S, Middelkoop E, Vranckx JJ, Bassetto F, Ziegler UE, Meaume S, et al. Updated scar management practical guidelines: non-invasive and invasive measures. JPlastReconstrAesthetSurg. 2014; 67: 1017-25.

[30]

Sue GR, Sun BJ, Lee GK. Complications after two-stage expander implant breast reconstruction requiring reoperation: a critical analysis of outcomes. AnnPlastSurg. 2018; 80: S292-4.

[31]

Lei J, Hou C, Duan P, Hao Z, Zhai Y, Meng Y. Clinical application of modified skin soft tissue expansion in early repair of devastating wound on the head due to electrical burn. ZhonghuaShaoShangZaZhi. 2015; 31: 406-9.

[32]

Essebag V, Verma A, Healey JS, Krahn AD, Kalfon E, Coutu B, et al. Clinically significant pocket hematoma increases long-term risk of device infection: BRUISE CONTROL INFECTION study. JAmCollCardiol. 2016; 67: 1300-8.

[33]

Cheung EV, Sperling JW, Cofield RH. Infection associated with hematoma formation after shoulder arthroplasty. ClinOrthopRelatRes. 2008; 466: 1363-7.

[34]

Ostaszewska A, Wszola M, Olszewska N, Karpeta E, Serwanska-Swietek M, Kuthan R, et al. Reoperation in early kidney post-transplant period as a strong risk factor of surgical site infection occurrence. TransplantProc. 2019; 51: 2724-30.

[35]

Hinds PR, Wilson SK, Sadeghi-Nejad H. Dilemmas of inflatable penile prosthesis revision surgery: what practices achieve the best outcomes and the lowest infection rates? (CME). JSexMed. 2012; 9: 2483-91.

[36]

Zhu M, Zhang D, Ye X, Ma X, Guo X. Risk factors of infection after skin soft tissue expansion. ZhonghuaZhengXingWaiKeZaZhi. 2019; 35: 986-90.

[37]

Azadgoli B, Fahradyan A, Wolfswinkel EM, Tsuha M, Magee W, 3rd, Hammoudeh JA, et al. External port tissue expansion in the Pediatric population: confirming its safety and efficacy. PlastReconstrSurg. 2018; 141: 883e-90e.

[38]

Thabane L, Mbuagbaw L, Zhang S, Samaan Z, Marcucci M, Ye C, et al. A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol. 2013. https://doi.org/10.1186/1471-2288-13-92.

[39]

Sessler DI, Imrey PB. Clinical research methodology 2: observational clinical research. AnesthAnalg. 2015; 121: 1043-51.

[40]

Chang H, Zhou B, Cui X, Su Y, Ma X. Analysis of the bacteria spectrum and clinical treatment of topical skin infection during soft tissue expander implantation. ZhonghuaZhengXingWaiKeZaZhi. 2016; 32: 191-5.

[41]

Wei M, Liu YJ, Li ZL, Wang ZG, Zhu JL. Clinical effect of arthroscopic debridement and infusion-drainage on septic arthritis after arthroscopic anterior cruciate ligament reconstruction. ZhongguoGuShang. 2015; 28: 279-81.

PDF (654KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉